Recent Articles By The Author
Dynavax Technologies, Kala Pharmaceuticals and TherapeuticsMD are three names this biotech investor plans to add exposure to via covered calls.
Gold Resource Corp. should benefit as inflationary pressures rise and Travelzoo should improve as normal life returns.
Shares of Cara Therapeutics, Adverum Biotechnologies and Ardelyx Inc. all took big hits after each company announced unfavorable developments.
There are similarities between conditions more than 50 years ago and the present state of affairs that should give investors cause for concern.
The administration's actions and plans aren't friendly to either investors or business operators.
This simple option strategy, which I continue to use with small-cap biotechs, is one of the easiest and cheapest risk mitigation approaches an individual can take.
Large purchases of Cortexyme Inc. and NantHealth Inc. shares have been made by insiders recently.
I have become a huge devotee of this simple option strategy. Here are two recent examples from this week.